Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/25/2014 08/26/2014 08/27/2014 08/28/2014 08/29/2014 Date
18.19(c) 18.63(c) 18.59(c) 18.32(c) 18.6(c) Last
797 319 894 781 521 428 501 065 406 786 Volume
-1.52% +2.42% -0.21% -1.45% +1.53% Change
More quotes
Company
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company. It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic... 
Sector
Pharmaceuticals
Calendar
09/10 | 10:55amPresentation
Surperformance© rating of Auxilium Pharmaceuticals,
Trading Rating : Investor Rating :
More about the company
Chart AUXILIUM PHARMACEUTICALS,
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 386 M
EBIT 2014 -5,11 M
Net income 2014 -117 M
Debt 2014 464 M
Yield 2014 -
Sales 2015 485 M
EBIT 2015 74,3 M
Net income 2015 13,3 M
Debt 2015 431 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 3,62x
EV / Sales 2015 2,82x
Capitalization 937 M
More Financials
Latest news on AUXILIUM PHARMACEUTICALS,
5d ago AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
5d ago AUXILIUM PHARMACEUTICALS : To Present CCH Data For Concurrent Treatment Of Multi..
6d ago AUXILIUM PHARMACEUTICALS : Announces Positive Data From Phase 2a Study Of CCH In..
6d ago AUXILIUM PHARMACEUTICALS : To Present At The Morgan Stanley Healthcare Conferenc..
08/21 AUXILIUM PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
08/21 AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
08/21 AUXILIUM PHARMACEUTICALS : Announces Positive Data From Phase 2a Study Of CCH In..
08/18 AUXILIUM PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial..
08/11 AUXILIUM PHARMACEUTICALS : Change in Directors or Principal Officers, Regulation..
08/11 AUXILIUM PHARMACEUTICALS : Appoints Andrew Saik Chief Financial Officer
08/07 AUXILIUM PHARMACEUTICALS : Results of Operations and Financial Condition, Regula..
08/07 AUXILIUM PHARMACEUTICALS : Announces Second Quarter 2014 Financial Results
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
Auxilium Pharmaceuticals,  : Income Statement Evolution
More Financials
EPS Revisions
Auxilium Pharmaceuticals,  : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF